Overview
French growth venture investor with exposure to diabetes technology, telemedicine and therapies for neurological diseases.
Unlock the full profileGet the complete company dossier
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.